♟️ Wednesday 23 July 2025 Wed, 23 July 2025

Patrys Limited has announced a fully underwritten entitlement offer to raise approximately $1.77 million, aimed at funding ongoing research and development of its PAT-DX3 therapy and supporting working capital. The offer includes secondary options and shares, subject to shareholder approval, and will significantly expand the company's capital base.

Yowie Group Limited has explained the delayed filing of director interest notices following a contested board change, committing to stronger governance measures to prevent future lapses.

Raptis Group Limited has confirmed that director James Raptis will resign effective 30 September 2025, affirming the company’s compliance with ASX continuous disclosure rules.

Winchester Energy Limited’s shares have been suspended from ASX trading due to a failure to meet director requirements under the Corporations Act, raising questions about its governance and future compliance.

Ardea Resources is progressing its Kalgoorlie Nickel Project with a fully funded Definitive Feasibility Study by Sumitomo Metal Mining and Mitsubishi Corporation, aiming to deliver a long-life, low-cost nickel-cobalt supply from Australia’s largest resource.

Lincoln Minerals Limited has unveiled a comprehensive update on its critical minerals projects in South Australia’s Gawler Craton, highlighting imminent drilling approvals at the Minbrie copper-base metals project and strong progress across graphite, uranium, and high purity iron assets.

Agrimin Limited progresses its Mackay Potash Project with ongoing strategic review and strong stakeholder backing, while securing $2.5 million through equity placement and completing the Tali Resources IPO.

Fat Prophets Global Contrarian Fund has announced a fully franked special dividend of 5 cents per share, reflecting strong investment performance. The dividend reinvestment plan offers shareholders a 2.5% discount on reinvested shares, signaling confidence in future growth.

Karoon Energy announces CEO Dr Julian Fowles will depart by mid-2026 as the company relocates key corporate roles to Brazil and the USA, initiating a global search for a Houston-based successor.

Astute Metals NL sharpens its focus on Nevada’s rich mineral landscape, unveiling fresh high-grade gold targets at Needles and reaffirming lithium potential at Red Mountain amid leadership changes.

Amplia Therapeutics has launched a $27.5 million capital raising to advance its lead drug Narmafotinib, a promising FAK inhibitor showing superior efficacy in pancreatic cancer trials. The funds will support ongoing and new clinical studies, positioning the company for pivotal regulatory milestones.

IperionX has successfully commissioned its Virginia titanium manufacturing campus, secured a substantial U.S. Department of Defense contract, and raised $46 million to fast-track production expansion through 2030.

Aerometrex has completed a strategic review that delivers $2 million in cost savings and initiates data monetisation, positioning the company for accelerated growth in FY26.

DigitalX Limited has expanded its Bitcoin holdings by acquiring an additional 74.7 BTC, pushing its total treasury value beyond A$100 million and reinforcing its Bitcoin-first strategy.

Highfield Resources has entered a significant non-binding agreement with China’s Qinghai Salt Lake Industry for a US$300 million equity injection, aiming to fast-track its Muga potash mine development and expand its global footprint.

Emmerson Resources’ latest Scoping Study confirms the White Devil Gold Project as a Major Mine, projecting robust financial returns and a seven-year mine life. With feasibility studies underway and a strategic JV structure, the project is poised for development in the Northern Territory.

West Wits Mining has released an updated Definitive Feasibility Study for its Qala Shallows project, revealing significant financial improvements and increased ore reserves. The study highlights a stronger gold price environment and refined mine plans that reduce capital requirements and accelerate payback.

Cygnus Metals reports standout drilling results at its Chibougamau project, highlighting the new Golden Eye prospect and Corner Bay deposit, supported by a strong A$18.3 million capital raise to accelerate development.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart technology, reporting promising clinical results in Crohn’s disease and GVHD, alongside a $3.5 million capital raise to fuel next-stage development.

Elsight Limited reports record-breaking revenue growth in Q2 and H1 2025, driven by major defence contracts and expanding market opportunities, positioning the company for profitability later this year.

Elsight Limited reports a record 340% revenue surge to US$4.8 million in the first half of 2025, backed by a robust US$11.45 million contract backlog and a strategic A$60 million capital raise to fuel expansion.

Encounter Resources has appointed key experts to accelerate development of its Aileron niobium-rare earth project, advancing metallurgical testing and market engagement.

Woodside Energy reported a 2% rise in quarterly production and lowered unit costs, while the Louisiana LNG Project’s final investment decision and a major Stonepeak partnership unlock significant future value.

Austco Healthcare reports robust FY25 growth with revenue climbing over 37% and EBITDA soaring by more than 54%, fueled by strong organic performance and key acquisitions.